Ventas (NYSE:VTR) Reaches New 52-Week High After Analyst Upgrade

Ventas, Inc. (NYSE:VTR)’s stock price reached a new 52-week high during mid-day trading on Monday after JPMorgan Chase & Co. raised their price target on the stock from $93.00 to $94.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Ventas traded as high as $88.76 and last traded at $88.1150, with a volume of 446645 shares traded. The stock had previously closed at $87.26.

Several other research analysts also recently issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price target on shares of Ventas in a research note on Monday, February 9th. Evercore reiterated an “outperform” rating and set a $95.00 price objective on shares of Ventas in a research report on Wednesday, April 29th. UBS Group lifted their price objective on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Citigroup lifted their price objective on Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Finally, Mizuho lifted their price objective on Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 4th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $93.56.

Insider Buying and Selling

In related news, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.53% of the company’s stock.

Institutional Trading of Ventas

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. PNC Financial Services Group Inc. grew its holdings in Ventas by 6.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 69,827 shares of the real estate investment trust’s stock valued at $5,710,000 after buying an additional 4,079 shares during the period. Oslo Pensjonsforsikring AS purchased a new stake in Ventas in the 1st quarter valued at about $62,000. Dimensional Fund Advisors LP grew its holdings in Ventas by 3.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 7,190,594 shares of the real estate investment trust’s stock valued at $588,045,000 after buying an additional 253,019 shares during the period. Parallel Advisors LLC grew its holdings in Ventas by 12.3% in the 1st quarter. Parallel Advisors LLC now owns 5,069 shares of the real estate investment trust’s stock valued at $415,000 after buying an additional 555 shares during the period. Finally, AlphaCentric Advisors LLC purchased a new stake in Ventas in the 1st quarter valued at about $291,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Up 0.3%

The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The company has a market cap of $42.57 billion, a PE ratio of 159.20, a PEG ratio of 2.15 and a beta of 0.74. The firm has a fifty day simple moving average of $84.81 and a 200 day simple moving average of $80.56.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s quarterly revenue was up 22.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities research analysts predict that Ventas, Inc. will post 3.85 EPS for the current year.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.